Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Development and Validation of Early Detection Biomarkers for Liver Cancer | Xuehong Zhang | Harvard Medical School and Brigham and Women's Hospital | PLCO | Jan 30, 2024 | 2023-0085 |
| Spatial Interplay of Tumor-Infiltrating Lymphocytes and Cancer Cells Identify Low-Risk Patients with Favorable Prognosis across Multiple Gastrointestinal Cancers | Anant Madabhushi | Emory University | PLCO | Jan 30, 2024 | PLCOI-1468 |
| Fat quality index and the risk of all-cause and cause-specific mortality in PLCO study | Linglong Peng | The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. | PLCO | Jan 26, 2024 | PLCO-1463 |
| Effect of diet score on the incidence of gastric cancer | Tian Le | China Medical University | PLCO | Jan 26, 2024 | PLCO-1456 |
| Early Detection and Personalized Treatment of Colon Cancer: Integrating Genetic, Demographic, and Lifestyle Data | JULIET KURUVILLA | HOWARD UNIVERSITY | PLCO | Jan 26, 2024 | PLCO-1460 |
| A study using AI methods to examine the effects of malnutrition on cancer patients' life expectancies | Shaesta Mujawar | P. G. Department of Computer Science, S.N.D.T. Women's University | PLCO | Jan 26, 2024 | PLCO-1455 |
| Study of causal relationship between lifestyle and disease demographic with chest X-Ray imaging features in healthy patients | Thomas Yui Chi Hung | Detect Medical Technology Limited | PLCO | Jan 26, 2024 | PLCOI-1444 |
| Evolution of cancer stage and mortality in the PLCO trial (NCI Version) | Eric Miller | NCI | PLCO | Jan 22, 2024 | PLCO-1462 |
| Time course of biomarkers | Paul Pinsky | DCP, NCI | PLCO | Jan 18, 2024 | PLCO-1454 |
| Predicting Prostate cancer Tissue type with machine learning | Md. Salman Karim Khan | Chittagong Medical College | PLCO | Jan 17, 2024 | PLCO-1450 |
| Lung Cancer Risk Analysis | Danbir Rashid | Leading University | PLCO | Jan 16, 2024 | PLCO-1447 |
| Ovarian Cancer Classification | Lakshmi kumari | Puducherry Technological University | PLCO | Jan 16, 2024 | PLCO-1443 |
| Cancer risk assessment by GAGome - a noninvasive biomarker for risk-stratified multi-cancer early detection | Volker Liebenberg | Elypta AB | PLCO | Jan 16, 2024 | 2023-0081 |
| A Deep Learning Approach for Prostate Cancer Screening | Julio Cesar Gali | Pontifícia Universidade Católica de São Paulo | PLCO | Jan 11, 2024 | PLCO-1440 |
| Validation of proteomic assay for early detection of pancreatic cancer using PLCO pre-diagnostic specimens | Ru Chen | Baylor College of Medicine | PLCO | Jan 11, 2024 | 2023-0088 |
| AI-based prognosis and therapy response prediction from pathology images | Iurii Tolkach | Institute of Pathology, University Hospital Cologne | PLCO | Jan 9, 2024 | PLCOI-1441 |
| Pan-cancer digital pathology AI foundation model and its application in cancer prognostication | Jan Witowski | Ataraxis AI, Inc. | PLCO | Jan 9, 2024 | PLCOI-1433 |
| The association between Energy-adjusted Dietary Inflammatory Index (E-DII) and lung cancer: a large prospective cohort | Haitao Gu | The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. | PLCO | Jan 9, 2024 | PLCO-1442 |
| Association between diet inhabit and prostate cancer risk | Emily Xing | Zhejiang hospital | PLCO | Jan 9, 2024 | PLCO-1436 |
| Risk prediction of prostate cancer mortality in a screening cohort. | Patrick Lewicki | University of Michigan | PLCO | Jan 9, 2024 | PLCO-1439 |